Abstract
Objective
To assess the technical feasibility and safety of combined fusion imaging and needle tracking under ultrasound guidance to target bone lesions without cortical disruption.
Materials and Methods
Between January 2016 and March 2016, seven patients underwent US-guided biopsy of bone lesions without cortical disruption. Targeted bone lesions were measuring more than 1.5 cm with a thin cortex, a trans-osseous pathway not exceeding 2 cm and without any adjacent vulnerable structures. First three procedures were performed in the CT suite to aid the needle tracking where necessary (group 1), the remaining four procedures were performed in the US suite (group 2). In group 1, deviation from the real position of the bone trocar (estimated on CT) was compared to the virtual position (estimated on the fusion CT–US images). In both group, procedure data and histopathological results were collected, and compared to the suspected diagnosis and follow-up.
Results
Mean procedure duration was 44 min. Total number of synchronisation points for combined fusion imaging were 3.3 on average. In group 1, mean deviation between the virtual and real CT coordinates was 5.3 mm on average. All biopsies yielded adequate quality analysable bone sample. Histopathological analysis revealed malignancy in three cases, non-specific inflammation in two cases, and normal bone in two cases. The four benign results were confirmed as true negative results. There were no immediate or post-procedural complications.
Conclusion
The use of combined fusion imaging and needle tracking ultrasound guidance to target bone lesions without cortical disruption seems technically feasible, provided the patient and lesion selection is appropriate.
References
Vieillard MH, Boutry N, Chastanet P, Duquesnoy B, Cotten A, Cortet B. Contribution of percutaneous biopsy to the definite diagnosis in patients with suspected bone tumor. Joint Bone Spine. 2005;72(1):53–60.
Monfardini L, Preda L, Aurilio G, Rizzo S, Bagnardi V, Renne G, Maccagnoni S, Vigna PD, Davide D, Bellomi M. CT-guided bone biopsy in cancer patients with suspected bone metastases: retrospective review of 308 procedures. Radiol Med. 2014;119(11):852–60. doi:10.1007/s11547-014-0401-4.
Tselikas L, Joskin J, Roquet F, Farouil G, Dreuil S, Hakimé A, Teriitehau C, Auperin A, de Baere T, Deschamps F. Percutaneous bone biopsies: comparison between flat-panel cone-beam CT and CT-scan guidance. Cardiovasc Intervent Radiol. 2015;38(1):167–76. doi:10.1007/s00270-014-0870-9.
Le HB, Lee ST, Munk PL. Image-guided musculoskeletal biopsies. Semin Intervent Radiol. 2010;27(2):191–8. doi:10.1055/s-0030-1253517.
Saifuddin A, Mitchell R, Burnett SJ, Sandison A, Pringle JA. Ultrasound-guided needle biopsy of primary bone tumours. J Bone Joint Surg Br. 2000;82(1):50–4.
Kongnyuy M, George AK, Rastinehad AR, Pinto PA. Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy: review of technology, techniques, and outcomes. Curr Urol Rep. 2016;17(4):32. doi:10.1007/s11934-016-0589-z.
Song KD, Lee MW, Rhim H, Cha DI, Chong Y, Lim HK. Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. AJR Am J Roentgenol. 2013;201(5):1141–7. doi:10.2214/AJR.13.10532.
Makino Y, Imai Y, Ohama H, Igura T, Kogita S, Sawai Y, Fukuda K, Takamura M, Ohashi H, Murakami T. Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography. Oncology. 2013;84(Suppl 1):44–50. doi:10.1159/000345889.
Hakime A, Deschamps F, De Carvalho EG, Barah A, Auperin A, De Baere T. Electromagnetic-tracked biopsy under ultrasound guidance: preliminary results. Cardiovasc Intervent Radiol. 2012;35(4):898–905. doi:10.1007/s00270-011-0278-8.
Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23(6):727–36.
Khalil JG, Mott MP, Parsons TW 3rd, Banka TR, van Holsbeeck M. 2011 mid-America orthopaedic association Dallas B. Phemister physician in training award: Can musculoskeletal tumors be diagnosed with ultrasound fusion-guided biopsy? Clin Orthop Relat Res. 2012;470(8):2280–7. doi:10.1007/s11999-012-2405-5.
Crocetti L, Lencioni R, Debeni S, See TC, Pina CD, Bartolozzi C. Targeting liver lesions for radiofrequency ablation: an experimental feasibility study using a CT–US fusion imaging system. Invest Radiol. 2008;43(1):33–9.
Zhao Y, Shen Y, Bernard A, Cachard C, Liebgott H. Evaluation and comparison of current biopsy needle localization and tracking methods using 3D ultrasound. Ultrasonics. 2017;73:206–20. doi:10.1016/j.ultras.2016.09.006.
Appelbaum L, Solbiati L, Sosna J, Nissenbaum Y, Greenbaum N, Goldberg SN. Evaluation of an electromagnetic image-fusion navigation system for biopsy of small lesions: assessment of accuracy in an in vivo swine model. Acad Radiol. 2013;20(2):209–17. doi:10.1016/j.acra.2012.09.020.
März K, Franz AM, Seitel A, Winterstein A, Hafezi M, Saffari A, Bendl R, Stieltjes B, Meinzer HP, Mehrabi A, Maier-Hein L. Interventional real-time ultrasound imaging with an integrated electromagnetic field generator. Comput Assist Radiol Surg. 2014;9(5):759–68. doi:10.1007/s11548-014-0990-3.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Julien Garnon received fees from Toshiba for oral presentations. All other authors have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Garnon, J., Koch, G., Tsoumakidou, G. et al. Ultrasound-Guided Biopsies of Bone Lesions Without Cortical Disruption Using Fusion Imaging and Needle Tracking: Proof of Concept. Cardiovasc Intervent Radiol 40, 1267–1273 (2017). https://doi.org/10.1007/s00270-017-1638-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-017-1638-9